Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Statera Biopharma, Inc. (STAB) had Receiveable Turnover of 6.88 for the most recently reported fiscal year, ending 2021-12-31.
| Income Statement Financials | |
$1.49M |
|
$-101.85M |
|
$0.49M |
|
$1.00M |
|
$99.83M |
|
$-98.34M |
|
$-3.53M |
|
$-101.88M |
|
$-101.88M |
|
$-101.88M |
|
$-101.88M |
|
$-101.88M |
|
$-101.88M |
|
$-98.34M |
|
$-98.09M |
|
35.11M |
|
35.11M |
|
$-2.90 |
|
$-2.90 |
|
| Balance Sheet Financials | |
$4.15M |
|
$0.20M |
|
$17.02M |
|
$21.17M |
|
$11.25M |
|
$10.62M |
|
$11.43M |
|
$22.68M |
|
$-1.51M |
|
$-12.35M |
|
$-1.51M |
|
35.48M |
|
| Cash Flow Statement Financials | |
$-28.19M |
|
$13.46M |
|
$20.99M |
|
$0.59M |
|
$6.84M |
|
$6.25M |
|
$6.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.37 |
|
-- |
|
-- |
|
1.17 |
|
-10.09 |
|
67.16% |
|
-6613.41% |
|
-6613.41% |
|
-6596.22% |
|
-6850.89% |
|
-6849.25% |
|
$-28.38M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
|
Receiveable Turnover |
6.88 |
53.06 |
|
6761.14% |
|
824.58% |
|
-481.23% |
|
-1117.27% |
|
$-0.04 |
|
$-0.81 |
|
$-0.80 |
|